Literature DB >> 27600050

Ex Vivo Maturation Assay for Testing Antimalarial Sensitivity of Rodent Malaria Parasites.

Zi Wei Chang1,2, Benoit Malleret1,2, Bruce Russell2,3, Laurent Rénia4,2, Carla Claser4.   

Abstract

Ex vivo assay systems provide a powerful approach to studying human malaria parasite biology and to testing antimalarials. For rodent malaria parasites, short-term in vitro culture and ex vivo antimalarial susceptibility assays are relatively cumbersome, relying on in vivo passage for synchronization, since ring-stage parasites are an essential starting material. Here, we describe a new approach based on the enrichment of ring-stage Plasmodium berghei, P. yoelii, and P. vinckei vinckei using a single-step Percoll gradient. Importantly, we demonstrate that the enriched ring-stage parasites develop synchronously regardless of the parasite strain or species used. Using a flow cytometry assay with Hoechst and ethidium or MitoTracker dye, we show that parasite development is easily and rapidly monitored. Finally, we demonstrate that this approach can be used to screen antimalarial drugs.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27600050      PMCID: PMC5075096          DOI: 10.1128/AAC.01292-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Antimalarial drugs clear resistant parasites from partially immune hosts.

Authors:  P Cravo; R Culleton; P Hunt; D Walliker; M J Mackinnon
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

2.  Methylene blue inhibits the asexual development of vivax malaria parasites from a region of increasing chloroquine resistance.

Authors:  Rossarin Suwanarusk; Bruce Russell; Alice Ong; Kanlaya Sriprawat; Cindy S Chu; Aung PyaePhyo; Benoit Malleret; François Nosten; Laurent Renia
Journal:  J Antimicrob Chemother       Date:  2014-08-21       Impact factor: 5.790

3.  Spiroindolones, a potent compound class for the treatment of malaria.

Authors:  Matthias Rottmann; Case McNamara; Bryan K S Yeung; Marcus C S Lee; Bin Zou; Bruce Russell; Patrick Seitz; David M Plouffe; Neekesh V Dharia; Jocelyn Tan; Steven B Cohen; Kathryn R Spencer; Gonzalo E González-Páez; Suresh B Lakshminarayana; Anne Goh; Rossarin Suwanarusk; Timothy Jegla; Esther K Schmitt; Hans-Peter Beck; Reto Brun; Francois Nosten; Laurent Renia; Veronique Dartois; Thomas H Keller; David A Fidock; Elizabeth A Winzeler; Thierry T Diagana
Journal:  Science       Date:  2010-09-03       Impact factor: 47.728

4.  The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action.

Authors:  D J Knight; W Peters
Journal:  Ann Trop Med Parasitol       Date:  1980-08

5.  Variable expression of virulence in the rodent malaria parasite Plasmodium yoelii yoelii.

Authors:  G Knowles; D Walliker
Journal:  Parasitology       Date:  1980-08       Impact factor: 3.234

6.  Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration.

Authors:  Blandine Franke-Fayard; Chris J Janse; Margarida Cunha-Rodrigues; Jai Ramesar; Philippe Büscher; Ivo Que; Clemens Löwik; Peter J Voshol; Marion A M den Boer; Sjoerd G van Duinen; Maria Febbraio; Maria M Mota; Andrew P Waters
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-28       Impact factor: 11.205

Review 7.  Methylene blue as an antimalarial agent.

Authors:  R Heiner Schirmer; Boubacar Coulibaly; August Stich; Michael Scheiwein; Heiko Merkle; Jana Eubel; Katja Becker; Heiko Becher; Olaf Müller; Thomas Zich; Wolfgang Schiek; Bocar Kouyaté
Journal:  Redox Rep       Date:  2003       Impact factor: 4.412

8.  Time-lapse imaging of red blood cell invasion by the rodent malaria parasite Plasmodium yoelii.

Authors:  Kazuhide Yahata; Moritz Treeck; Richard Culleton; Tim-Wolf Gilberger; Osamu Kaneko
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

9.  One-step concentration of malarial parasite-infected red blood cells and removal of contaminating white blood cells.

Authors:  Dai Thi Xuan Trang; Nguyen Tien Huy; Tohru Kariu; Kunihiko Tajima; Kaeko Kamei
Journal:  Malar J       Date:  2004-03-17       Impact factor: 2.979

10.  A novel multiple-stage antimalarial agent that inhibits protein synthesis.

Authors:  Beatriz Baragaña; Irene Hallyburton; Marcus C S Lee; Neil R Norcross; Raffaella Grimaldi; Thomas D Otto; William R Proto; Andrew M Blagborough; Stephan Meister; Grennady Wirjanata; Andrea Ruecker; Leanna M Upton; Tara S Abraham; Mariana J Almeida; Anupam Pradhan; Achim Porzelle; María Santos Martínez; Torsten Luksch; Judith M Bolscher; Andrew Woodland; Suzanne Norval; Fabio Zuccotto; John Thomas; Frederick Simeons; Laste Stojanovski; Maria Osuna-Cabello; Paddy M Brock; Tom S Churcher; Katarzyna A Sala; Sara E Zakutansky; María Belén Jiménez-Díaz; Laura Maria Sanz; Jennifer Riley; Rajshekhar Basak; Michael Campbell; Vicky M Avery; Robert W Sauerwein; Koen J Dechering; Rintis Noviyanti; Brice Campo; Julie A Frearson; Iñigo Angulo-Barturen; Santiago Ferrer-Bazaga; Francisco Javier Gamo; Paul G Wyatt; Didier Leroy; Peter Siegl; Michael J Delves; Dennis E Kyle; Sergio Wittlin; Jutta Marfurt; Ric N Price; Robert E Sinden; Elizabeth A Winzeler; Susan A Charman; Lidiya Bebrevska; David W Gray; Simon Campbell; Alan H Fairlamb; Paul A Willis; Julian C Rayner; David A Fidock; Kevin D Read; Ian H Gilbert
Journal:  Nature       Date:  2015-06-18       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.